CASCADE®
Autologous Platelet System
Interest in fibrin clot techniques and the expanded application of growth factors in soft tissue and bone repair have led to the development of the CASCADE® Autologous Platelet System. Cascade employs platelets and their associated growth factors for clinical applications that require rapid healing and tissue regeneration.¹ The Cascade system represents An Evolution In Platelet Therapy, producing PRFM that can be delivered arthroscopically and sutured into a repair site to stimulate a healing response. The PRFM implant represents a potentially more precise technique to deliver a more concentrated and volume stable fibrin matrix rich in platelets.² Growth factors within the PRFM remain functionally viable throughout the Cascade process and are continually released over seven days.³
Only MTF has a complete offering of platelet-rich plasma therapies including PRP, Membrane and Matrix.
| |
|
| 910048 |
Cascade Autologous Platelet System, PRFM x2 |
| 910050 |
Cascade Autologous Platelet System, PRFM |
| 910058 |
Drucker General Purpose Centrifuge w/ Locking Lid |
| |
|
| |
|
| 910044 |
Cascade Autologous Platelet System, Membrane |
| 910060 |
Drucker General Purpose Centrifuge II w/ Locking Lid |
| |
|
| |
Click for Patient Info |
| 910045 |
Spray Tip Applicator (10 per box) |
| 910046 |
Cascade Autologous Platelet System, PRP |
| 910047 |
Cascade Autologous Platelet System, PRP x2 |
| 910058 |
Drucker General Purpose Centrifuge w/ Locking Lid |
| |
|
1. Anitua E, Andia I, et al. Thromb Haemost; 91(1):4-15; 2004.
2. Angel MJ, Sgaglione NA, et al. Sports Med Arthrosc Rev:138-145; 2006
3. Visser and Arnoczky, et al. Veterinary Surgery. 2010
)
)
)
)
)
)
)
)
)
)